Phase II Study to Evaluate Efficacy and Safety of Capecitabine + Cisplatin Combination Therapy in Gastric Cancer Patients Who Relapsed After S-1 Adjuvant Chemotherapy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms XParTS
- 26 Jul 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 26 Jul 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 02 Feb 2016 Planned End Date changed from 1 May 2015 to 1 Dec 2016 as reported in ClinicalTrials.gov record.